Literature DB >> 3803423

Elimination of brotizolam in elderly patients after multiple doses.

W D Bechtel, E Goetzke.   

Abstract

Plasma brotizolam levels were measured in 5 elderly patients given 0.25 mg daily. The half-life of brotizolam elimination was 6.0 h after a single dose and 6.9 h after continuous administration for 3 weeks. The brotizolam concentration in plasma 2 h after the dose was 3.5 and 3.4 ng/ml, respectively, on the first and last days of the study. Brotizolam levels measured several times during the study 10 h after dosing were between 1.2 and 1.8 ng/ml. Thus, administration of brotizolam 0.25 mg/d to elderly patients for 3 weeks led neither to its accumulation nor to faster elimination. The half-life of brotizolam elimination in elderly patients was in the upper range of that found in young volunteers.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3803423     DOI: 10.1007/bf00606668

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  18 in total

1.  Human aging and disease.

Authors:  R R KOHN
Journal:  J Chronic Dis       Date:  1963-01

2.  [Electroencephalographic assessment of dosage and sleep-profile in a hypnotic Triazolothienodiazepine (author's transl)].

Authors:  S Kubicki
Journal:  EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb       Date:  1979-06

Review 3.  Drug use in the elderly: a review of problems and special considerations.

Authors:  R E Vestal
Journal:  Drugs       Date:  1978-10       Impact factor: 9.546

4.  Pharmacokinetics of brotizolam in the elderly.

Authors:  R Jochemsen; K L Nandi; D Corless; J G Wesselman; D D Breimer
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

5.  Oxazepam kinetics: effects of age and sex.

Authors:  D J Greenblatt; M Divoll; J S Harmatz; R I Shader
Journal:  J Pharmacol Exp Ther       Date:  1980-10       Impact factor: 4.030

6.  Brotizolam radioimmunoassay: development, evaluation, and application to human plasma samples.

Authors:  W D Bechtel; K H Weber
Journal:  J Pharm Sci       Date:  1985-12       Impact factor: 3.534

7.  Pharmacokinetics and metabolism of brotizolam in animals.

Authors:  W D Bechtel
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

8.  Pharmacokinetics and metabolism of brotizolam in humans.

Authors:  W D Bechtel
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

9.  Studies on sleep and performance with a triazolo-1, 4-thienodiazepine (brotizolam).

Authors:  A N Nicholson; B M Stone; P A Pascoe
Journal:  Br J Clin Pharmacol       Date:  1980-07       Impact factor: 4.335

10.  Blood level, distribution, excretion, and metabolite pattern of [14C]-brotizolam in the rat, dog, and rhesus monkey.

Authors:  W D Bechtel; J Mierau; I Richter; M Stiasni
Journal:  Arzneimittelforschung       Date:  1986-03
View more
  2 in total

Review 1.  Hepatic drug metabolism and aging.

Authors:  C Durnas; C M Loi; B J Cusack
Journal:  Clin Pharmacokinet       Date:  1990-11       Impact factor: 6.447

Review 2.  Brotizolam. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy as an hypnotic.

Authors:  M S Langley; S P Clissold
Journal:  Drugs       Date:  1988-02       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.